Historically, clinical trials have under-represented women and minorities. Clinical Trial Media's Cara Brant offers ...

Clinical trial complexity has significantly increased in the past decade. How can the industry adapt and innovate to remain ...

The U.S. Food and Drug Administration has approved vimseltinib for adult patients with a rare condition called tenosynovial ...

People using semaglutide for diabetes or weight loss have also reported experiencing a reduced desire for alcohol.

Cleveland Clinic researchers are using artificial intelligence to identify existing FDA-approved drugs that may be repurposed to treat other complex diseases. The effort is led by Feixiong Cheng, PhD, ...

The Calgary Stroke Program, a joint University of Calgary and Alberta Health Services initiative at Foothills Medical Centre, ...

Objective: This study aims to investigate the drainage effect and clinical outcomes of negative pressure chest drainage in patients after two-port thoracoscopic valve surgery, comparing the ...

Layoffs, funding freezes, and executive orders spark outcry among federal researchers and university partners, fearing that science itself is under siege.

Elisa Cascade, CPO at Advarra explains why addressing the challenges faced by clinical research sites is vital for improving ...

Researchers at Penn Medicine conducted a pilot randomized controlled trial to test the hypothesis that an e-triage ...

With federal support, universities produce world-changing discoveries and the next generation of exquisitely well-trained ...

Ocrevus as a first-line treatment for early relapsing MS is better at delaying disease progression than starting with a less effective drug.